Skip NavigationSkip to Content

NCI at Frederick Scientific Publications Advanced Search

Search

  1. NCI-F Publications

  2. Return to Quick Search
Search
  2. Year Published:

Your search returned 37 results.
User Information
Export Records
  1. 1.   Two hearts beat as one: the debate over RAS dimers continues
  2. Stephen,Andy
  3. Trends in Biochemical Sciences. 2024, Nov; 49(11): 933-935.
  1. 2.   Nano-mupirocin as tumor-targeted antibiotic: Physicochemical, immunotoxicological and pharmacokinetic characterization, and effect on gut microbiome
  2. Cern, Ahuva; Skoczen,Sarah; Snapp, Kelsie S; Hod, Atara; Zilbersheid, Daniel; Bavli, Yaelle; Alon-Maimon, Tamar; Bachrach, Gilad; Wei, Xiaohui; Berman, Bella; Yassour, Moran; Cedrone,Edward; Neun,Barry; Dobrovolskaia,Marina; Clogston,Jeffrey; Stern,Steve; Barenholz, Yechezkel
  3. Journal of Controlled Release : official journal of the Controlled Release Society. 2024, Aug 2; 373: 713-726.
  1. 3.   Metastasis suppressor NME1 in exosomes or liposomes conveys motility and migration inhibition in breast cancer model systems
  2. Khan, Imran; Gril, Brunilde; Hoshino, Ayuko; Yang, Howard H; Lee, Maxwell P; Difilippantonio,Simone; Lyden, David C; Steeg, Patricia S
  3. Clinical & Experimental Metastasis. 2022, Aug 08;
  1. 4.   The importance of nanoparticle physicochemical characterization for immunology research: What we learned and what we still need to understand
  2. Clogston, Jeffrey D.
  3. Advanced Drug Delivery Reviews. 2021, Sep; 176
  1. 5.   Fully Processed Recombinant KRAS4b: Isolating and Characterizing the Farnesylated and Methylated Protein
  2. Agamasu,Constance; Frank,Peter; Perkins,Shelley; Waybright,Tim; Messing,Simon; Gillette,Bill; Stephen,Andy
  3. Journal of visualized experiments : JoVE. 2020, Jan 16; (155):
  1. 6.   Ion quantification in liposomal drug products using high performance liquid chromatography
  2. Wu, Jiewei; Crist,Rachael; McNeil,Scott; Clogston,Jeffrey
  3. Journal of pharmaceutical and biomedical analysis. 2019, Feb 20; 165: 41-46.
  1. 7.   Quantitative biophysical analysis defines key components modulating recruitment of the GTPase KRAS to the plasma membrane
  2. Bindu, Lakshman; Messing, Simon; Schmid, Eva M.; Clogston, Jeffrey; Gillette, Bill; Esposito, Dom; Kessing, Bailey; Fletcher, Daniel A.; Nissley, Dwight; McCormick, Frank; Stephen, Andy; Jean-Francois, Frantz
  3. JOURNAL OF BIOLOGICAL CHEMISTRY. 2019, Feb 8; 294(6): 2193-2207.
  1. 8.   Understanding the Role of Anti-PEG Antibodies in the Complement Activation by Doxil in Vitro
  2. Neun, Barry; Barenholz, Yechezkel; Szebeni, Janos; Dobrovolskaia, Marina
  3. Molecules. 2018, Jul 12; 23(7): pii: E1700.
  1. 9.   A lipid-based cell penetrating nano-assembly for RNAi-mediated anti-angiogenic cancer therapy
  2. Majumder, Poulami; Bhunia, Sukanya; Chaudhuri, Arabinda
  3. CHEMICAL COMMUNICATIONS. 2018, FEB 11; 54(12): 1489-1492.
  1. 10.   Anticoagulants Influence the Performance of In Vitro Assays Intended for Characterization of Nanotechnology-Based Formulations
  2. Cedrone, Edward; Neun, Barry; Rodriguez, Jamie; Vermilya, Alison; Clogston, Jeffrey; McNeil, Scott; Barenholz, Yechezkel; Szebeni, Janos; Dobrovolskaia, Marina
  3. Molecules . 2018, Jan; 23(1): pii: E12.
  1. 11.   Zeta potential: a case study of cationic, anionic, and neutral liposomes
  2. Smith, Mackensie C; Crist, Rachael; Clogston, Jeffrey; McNeil, Scott
  3. Analytical and bioanalytical chemistry. 2017, Sep; 409(24): 5779-5787.
  1. 12.   The Recombinant Sea Urchin Immune Effector Protein, rSpTransformer-E1, Binds to Phosphatidic Acid and Deforms Membranes
  2. Lun, Cheng Man; Samuel, Robin L.; Gillmor, Susan D.; Boyd, Anthony; Smith, L. Courtney
  3. Frontiers in Immunology. 2017, May 12; 8: 481.
  1. 13.   Coencapsulation of alendronate and doxorubicin in pegylated liposomes: a novel formulation for chemoimmunotherapy of cancer
  2. Shmeeda, Hilary; Amitay, Yasmine; Gorin, Jenny; Tzemach, Dina; Mak, Lidia; Stern, Steve; Barenholz, Yechezkel; Gabizon, Alberto
  3. JOURNAL OF DRUG TARGETING. 2016, Nov; 24(9): 878-889.
  1. 14.   Polymeric Lipid Assemblies as Novel Theranostic Tools
  2. Puri, A.; Blumenthal, R.
  3. Accounts of Chemical Research. 2011, Oct; 44(10): 1071-1079.
  1. 15.   Hyperthermia-triggered intracellular delivery of anticancer agent to HER2(+) cells by HER2-specific affibody (ZHER2-GS-Cys)-conjugated thermosensitive liposomes (HER2(+) affisomes)
  2. Smith, B.; Lyakhov, I.; Loomis, K.; Needle, D.; Baxa, U.; Yavlovich, A.; Capala, J.; Blumenthal, R.; Puri, A.
  3. Journal of Controlled Release. 2011, Jul; 153(2): 187-194.
  1. 16.   A novel class of photo-triggerable liposomes containing DPPC:DC8,9PC as vehicles for delivery of doxorubcin to cells
  2. Yavlovich, A.; Singh, A.; Blumenthal, R.; Puri, A.
  3. Biochimica Et Biophysica Acta-Biomembranes. 2011, Jan; 1808(1): 117-126.
  1. 17.   Chromatographic methods for the quantification of free and chelated gadolinium species in MRI contrast agent formulations
  2. Clevel, D.; Long, S. E.; Sander, L. C.; Davis, W. C.; Murphy, K. E.; Case, R. J.; Rimmer, C. A.; Francini, L.; Patri, A. K.
  3. Analytical and Bioanalytical Chemistry. 2010, Dec; 398(7-8): 2987-2995.
  1. 18.   Light-sensitive lipid-based nanoparticles for drug delivery: design principles and future considerations for biological applications
  2. Yavlovich, A.; Smith, B.; Gupta, K.; Blumenthal, R.; Puri, A.
  3. Molecular Membrane Biology. 2010, Oct; 27(7): 364-381.
  1. 19.   A Novel Nanoparticulate Formulation of Arsenic Trioxide with Enhanced Therapeutic Efficacy in a Murine Model of Breast Cancer
  2. Ahn, R. W.; Chen, F.; Chen, H. M.; Stern, S. T.; Clogston, J. D.; Patri, A. K.; Raja, M. R.; Swindell, E. P.; Parimi, V.; Cryns, V. L.; O'Halloran, T. V.
  3. Clinical Cancer Research. 2010, Jul; 16(14): 3607-3617.
  1. 20.   Specific targeting to B cells by lipid-based nanoparticles conjugated with a novel CD22-ScFv
  2. Loomis, K.; Smith, B.; Feng, Y.; Garg, H.; Yavlovich, A.; Campbell-Massa, R.; Dimitrov, D. S.; Blumenthal, R.; Xiao, X. D.; Puri, A.
  3. Experimental and Molecular Pathology. 2010, Apr; 88(2): 238-249.
  1. 21.   Minireview: Nanoparticles and the Immune System
  2. Zolnik, B. S.; Gonzalez-Fernandez, A.; Sadrieh, N.; Dobrovolskaia, M. A.
  3. Endocrinology. 2010, Feb; 151(2): 458-465.
  1. 22.   Nanomaterial standards for efficacy and toxicity assessment
  2. Adiseshaiah, P. P.; Hall, J. B.; McNeil, S. E.
  3. Wiley Interdisciplinary Reviews-Nanomedicine and Nanobiotechnology. 2010, Jan-Feb; 2(1): 99-112.
  1. 23.   Lipid-Based Nanoparticles as Pharmaceutical Drug Carriers: From Concepts to Clinic
  2. Puri, A.; Loomis, K.; Smith, B.; Lee, J. H.; Yavlovich, A.; Heldman, E.; Blumenthal, R.
  3. Critical Reviews in Therapeutic Drug Carrier Systems. 2009 26(6): 523-580.
  1. 24.   HER2-Specific Affibody-Conjugated Thermosensitive Liposomes (Affisomes) for Improved Delivery of Anticancer Agents
  2. Puri, A.; Kramer-Marek, G.; Campbell-Massa, R.; Yavlovich, A.; Tele, S. C.; Lee, S. B.; Clogston, J. D.; Patri, A. K.; Blumenthal, R.; Capala, J.
  3. Journal of Liposome Research. 2008 18(4): 293-307.
  1. 25.   Evaluation of a nanotechnology-based carrier for delivery of curcumin in prostate cancer cells
  2. Thangapazham, R. L.; Puri, A.; Tele, S.; Blumenthal, R.; Maheshwari, R. K.
  3. International Journal of Oncology. 2008 32(5): 1119-1123.
NCI at Frederick

You are leaving a government website.

This external link provides additional information that is consistent with the intended purpose of this site. The government cannot attest to the accuracy of a non-federal site.

Linking to a non-federal site does not constitute an endorsement by this institution or any of its employees of the sponsors or the information and products presented on the site. You will be subject to the destination site's privacy policy when you follow the link.

ContinueCancel